---
document_datetime: 2025-01-14 15:34:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pheburane-epar-all-authorised-presentations_en.pdf
document_name: pheburane-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7766979
conversion_datetime: 2025-12-23 00:48:40.749965
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
|                 | name      |           | Form          | Administration   | Packaging                                            | (concentration)                    |                                                                                      |
|-----------------|-----------|-----------|---------------|------------------|------------------------------------------------------|------------------------------------|--------------------------------------------------------------------------------------|
| EU/1/13/822/001 | PHEBURANE | 483 mg/g  | Granules      | Oral use         | bottle (HDPE)                                        | 174g                               | 1 bottle + 1 dosing spoon                                                            |
| EU/1/13/822/006 | PHEBURANE | 350 mg/ml | Oral solution | Oral use         | solution: bottle (glass); flavouring: bottle (glass) | solution: 100 ml; flavouring: 3 ml | 1 bottle + 1 dosing syringe with attached bottle adaptor + 2 flavour topping bottles |
| EU/1/13/822/007 | PHEBURANE | 350 mg/ml | Oral solution | Oral use         | solution: bottle (glass)                             | solution: 100 ml                   | 1 bottle + 1 dosing syringe with attached bottle adaptor                             |